What is the price-to-earnings ratio of IRIDEX?
The price-earnings ratio of IRIDEX is currently 0.77.
IRIDEX P/S 2024
IRIDEX P/S
0.77
Ticker
IRIX
ISIN
US4626841013
WKN
912341
As of Dec 26, 2024, IRIDEX's P/S ratio stood at 0.77, a 14.93% change from the 0.67 P/S ratio recorded in the previous year.
The IRIDEX P/S history
IRIDEX Aktienanalyse
What does IRIDEX do?
IRIDEX Corp is a global medical technology company that specializes in the development, manufacturing, marketing, and distribution of innovative laser-based medical devices and services. The company was originally founded in 1989 and is headquartered in Mountain View, California. IRIDEX's business model is divided into various divisions, each serving different markets. The divisions include ophthalmology, otolaryngology (ENT), gynecology and urology, as well as scientific research. The company offers a wide range of high-tech laser systems that can be used to treat various conditions, such as retinal diseases, glaucoma, nasal and throat disorders, gynecological and urological conditions, and other medical applications. One of the most well-known divisions of IRIDEX is ophthalmology, which offers a wide range of laser systems for the treatment of retinal diseases. These retinal diseases include diabetic retinopathy, retinal edema, age-related macular degeneration, and retinal detachment. The company also has a high-tech system called Cyclo G6TM, which is used for the treatment of glaucoma. This system can also be used in conjunction with other devices, such as ultrasound systems, for optimized clinical effectiveness. The ENT division offers laser systems for the treatment of nasal and throat disorders, such as snoring, polyps, stenosis, and tumors. The range of laser systems varies from simple systems to advanced systems that can be connected to a flexible endoscope for more precise treatment. IRIDEX's gynecology and urology division offers laser systems for various applications, such as urinary incontinence, bladder problems, tumor removal, prostate tissue removal, and medical treatments to improve sexual function. Laser systems can also be used in combination with other medical devices, such as ultrasound systems. The company places great emphasis on scientific research and development to create and introduce innovative technologies to the market. Therefore, IRIDEX collaborates closely with various research institutes, universities, and medical professionals to further develop its technological advances. The company is also committed to providing comprehensive training and support to its customers to ensure that they use the devices safely and effectively. Overall, IRIDEX Corp has established itself as an innovative and powerful multinational company in the field of medical technology. The company is constantly striving to expand its range of products and services and impress its customers with its high-quality solutions. IRIDEX is confident that it will continue to play a significant role in the medical technology industry in the future. IRIDEX ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding IRIDEX's P/S Ratio
IRIDEX's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing IRIDEX's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating IRIDEX's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in IRIDEX’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about IRIDEX stock
How has the price-earnings ratio of IRIDEX changed compared to last year?
The price-to-earnings ratio of IRIDEX has increased by 14.93% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of IRIDEX high compared to other companies?
Yes, the price-to-earnings ratio of IRIDEX is high compared to other companies.
How does an increase in the price-earnings ratio of IRIDEX affect the company?
An increase in the price-earnings ratio of IRIDEX would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of IRIDEX affect the company?
A decrease in the price-earnings ratio of IRIDEX would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of IRIDEX?
Some factors that influence the price-earnings ratio of IRIDEX are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does IRIDEX pay?
Over the past 12 months, IRIDEX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IRIDEX is expected to pay a dividend of 0 USD.
What is the dividend yield of IRIDEX?
The current dividend yield of IRIDEX is .
When does IRIDEX pay dividends?
IRIDEX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of IRIDEX?
IRIDEX paid dividends every year for the past 0 years.
What is the dividend of IRIDEX?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is IRIDEX located?
IRIDEX is assigned to the 'Health' sector.
Wann musste ich die Aktien von IRIDEX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of IRIDEX from 12/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/26/2024.
When did IRIDEX pay the last dividend?
The last dividend was paid out on 12/26/2024.
What was the dividend of IRIDEX in the year 2023?
In the year 2023, IRIDEX distributed 0 USD as dividends.
In which currency does IRIDEX pay out the dividend?
The dividends of IRIDEX are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von IRIDEX
Our stock analysis for IRIDEX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IRIDEX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
